Glucocorticoid (GC) and hypoxic transcriptional responses play a central role in tissue homeostasis and regulate the cellular response to stress and inflammation, highlighting the potential for cross-talk between these two signaling pathways. We present results from an unbiased in vivo chemical screen in zebrafish that identifies GCs as activators of hypoxia-inducible factors (HIFs) in the liver. GCs activated consensus hypoxia response element (HRE) reporters in a glucocorticoid receptor (GR)-dependent manner. Importantly, GCs activated HIF transcriptional responses in a zebrafish mutant line harboring a point mutation in the GR DNA-binding domain, suggesting a nontranscriptional route for GR to activate HIF signaling. We noted that GCs increase the transcription of several key regulators of glucose metabolism that contain HREs, suggesting a role for GC/HIF cross-talk in regulating glucose homeostasis. Importantly, we show that GCs stabilize HIF protein in intact human liver tissue and isolated hepatocytes. We find that GCs limit the expression of Von Hippel Lindau protein (pVHL), a negative regulator of HIF, and that treatment with the c-src inhibitor PP2 rescued this effect, suggesting a role for GCs in promoting c-src-mediated proteosomal degradation of pVHL. Our data support a model for GCs to stabilize HIF through activation of c-src and subsequent destabilization of pVHL.
Glucocorticoid (GC) and hypoxic transcriptional responses play a central role in tissue homeostasis and regulate the cellular response to stress and inflammation, highlighting the potential for cross-talk between these two signaling pathways. We present results from an unbiased in vivo chemical screen in zebrafish that identifies GCs as activators of hypoxia-inducible factors (HIFs) in the liver. GCs activated consensus hypoxia response element (HRE) reporters in a glucocorticoid receptor (GR)-dependent manner. Importantly, GCs activated HIF transcriptional responses in a zebrafish mutant line harboring a point mutation in the GR DNA-binding domain, suggesting a nontranscriptional route for GR to activate HIF signaling. We noted that GCs increase the transcription of several key regulators of glucose metabolism that contain HREs, suggesting a role for GC/HIF cross-talk in regulating glucose homeostasis. Importantly, we show that GCs stabilize HIF protein in intact human liver tissue and isolated hepatocytes. We find that GCs limit the expression of Von Hippel Lindau protein (pVHL), a negative regulator of HIF, and that treatment with the c-src inhibitor PP2 rescued this effect, suggesting a role for GCs in promoting c-src-mediated proteosomal degradation of pVHL. Our data support a model for GCs to stabilize HIF through activation of c-src and subsequent destabilization of pVHL.
hypoxia-inducible factor | glucocorticoid signaling | Von Hippel Lindau | metabolism | liver G lucocorticoids (GCs) are steroid hormones secreted from the adrenal glands that regulate carbohydrate, lipid, and protein metabolism. GCs are widely used as anti-inflammatory agents for treating pathological conditions where hypoxia plays a role in disease progression such as rheumatoid arthritis and chronic obstructive pulmonary disease. GCs and hypoxia pathways have a close interplay in physiology and disease (1) (2) (3) ; however, recent studies report conflicting results on the cross-talk between GC action and hypoxia (4, 5) . Hypoxia-inducible factors (HIFs) are oxygen-sensitive transcriptional complexes constituted by α-and β-subunits that activate diverse pathways regulating cellular glucose and lipid metabolism and proliferation (6, 7) . Under normoxic conditions, the HIF-1α transcriptional subunit is recognized by prolyl hydroxylases and targeted for degradation via the Von Hippel Lindau (VHL)-mediated ubiquitin proteasome pathway; however, under hypoxic conditions HIF-1α is stabilized and translocates to the nucleus to exert its transcriptional activity. HIFs play a central role in many disease processes and provide a therapeutic target for treating pathological conditions including cancer, ischemia, stroke, inflammation, and chronic anemia (8) (9) (10) (11) . Screens to identify agents that stabilize HIFs have identified numerous agents, with the majority acting either via iron chelation or as 2-oxyglutarate analogs (12) . In vitro HIFreporter screening methods, although extremely valuable, do not provide physiological information and may overlook tissue-specific activators that require a physiological context.
To identify regulators of the HIF pathway, we developed several HIF-reporter zebrafish lines (13) and completed an unbiased chemical screen. GCs activated HIF-associated transcriptional responses most prominently in the liver. Importantly, we translate these observations to human tissue and show that GCs stabilize HIF in primary human hepatocytes and intact liver slices. Our data support a model where GCs act via a transcriptional independent mechanism by activating c-src to repress Von Hippel Lindau (pVHL) expression and stabilize HIF protein under normoxic conditions. Our study identifies a role for GCs to stabilize HIF and to regulate liver glucose metabolism.
Results
GCs Activate Hypoxic Signaling. Prolyl hydroxylase 3 (PHD3) transcription is regulated by HIFs, and we used our zebrafish phd3:eGFP HIF-reporter line to screen a chemical library (Dataset S1) for HIF activators. Dimethyloxaloylglycine (DMOG), a well-established activator of HIF signaling, was used as a positive control (14) . Of the 41 initial hits, several GCs activated the reporter to comparable levels as DMOG (60 μM) (Fig. 1A) . We confirmed that two GR agonists, betamethasone 17,21-dipropanoate (BME) and dexamethasone (DEX), activated the reporter ( Fig. 1 B and C) . We
Significance
An in vivo chemical screen in zebrafish identified glucocorticoids (GCs) as activators of hypoxia-inducible factor transcriptional responses in the liver. This cross-talk is conserved in human liver and requires glucocorticoid receptor signaling but not DNA binding. In human liver cells, GCs down-regulate Von Hippel Lindau expression at a posttranscriptional level most likely through c-src-mediated proteasomal degradation. Since the liver is an important regulator of blood glucose and hypoxia-inducible factors regulate gluconeogenesis/glycogen synthesis, cross-talk between these transcriptional regulators may be essential to control glucose metabolism in the liver. This identified, conserved, noncanonical pathway may have wider physiological significance in health and disease.
noted increased phd3-GFP expression mainly in the liver (Fig.  1B) , suggesting that activation may be due to nonspecific stress as result of drug metabolism. To address this potential issue, reporter embryos were treated with GCs in the presence or absence of the GR antagonist RU-486 that reduced GFP intensity of BME-treated embryos ( Fig. 1 B and C) , while having minimal effect on DMOG-dependent activation (Fig. 1C) , demonstrating that GC-augmented phd3:eGFP activity is GR-dependent.
To characterize the effects of BME on endogenous hypoxiaassociated transcriptional responses, we quantified selected HIFresponsive genes (pfkfb3, p4ha1b, and hpx) and GR-responsive genes (tsc22d3, scarb1, fkbp5, and pepck1) (15-17) by qPCR. phd3:eGFP embryos [5 days postfertilization (dpf)] were treated with BME (10 μM) for 8 h before isolating RNA, the optimal time for phd3 induction. (Fig. S1) . BME induced the transcription of HIF-target genes to variable extents, albeit less than in a vhl mutant background, with hpx being the most responsive gene (Fig. 1D) . To determine whether BME activation of phd3:eGFP reporter is HIF dependent, we silenced Hif-1β expression, an essential binding partner of both HIF-1α and HIF-2α (18) . Hif-1β morphants were incubated with BME from 56 h postfertilization (hpf) until 72 hpf, and HIF-1β knockdown significantly reduced GFP intensity in the treated embryos compared with control morpholino (MO)-injected embryos (Fig. 1E) , demonstrating that GC activation of phd3:eGFP is HIF-dependent.
To confirm that GCs directly activate HIF-transcriptional activity, we created a HIF reporter zebrafish expressing tandem copies of a hypoxia response element (HRE) driving eGFP expression, named Tg(4xhre-tata:eGFP) ia21 . Reporter activity is decreased in Hif-1β morphants and increased by expression of a dominant active form of HIF-1α mRNA or DMOG treatment, confirming that the transgene responds to modulators of the HIF-1-signaling pathway ( Fig. 2 and Fig. S2 ). To examine the influence of GCs, the offspring obtained from a Tg(4xhre-tata:eGFP) ia21 carrier were exposed to increasing concentrations of DEX for 24 h. Treated embryos showed a dose-dependent activation of the 4xhre-tata transgene, confirming that GCs activate HIF transcriptional responses under normoxic conditions (Fig. 3A and Fig. S3A ). To independently assess whether GCs affect HIF-1 signaling and the glycolytic pathway, we analyzed the expression of three known hypoxia-dependent regulators of glucose metabolism in zebrafish (19) using wholemount in situ hybridization (WISH); as expected, pfkfb3, ldha, and glut1 were up-regulated after DEX treatment as a consequence of HIF-1 activation (Fig. S3B ).
GC Activation of HIF Is Independent of GR DNA Binding. GCs regulate gene transcription through binding and activating cytoplasmic GR, through nuclear translocation, and through direct binding to GC response elements (GRE) (20) . To analyze the mechanism AMC, amcinonide; BME, betamethasone; CBP, clobetasol propionate; CPO, ciclopirox olamine; DEX, dexamethasone; DFL, 8,2-dimethoxyflavone; FLC, fluocinonide; HAL, halcinonide; HCB, hydrocortisone butyrate; ICA, icariin; NIN, 7-nitroindazole; PTE, ptaeroxylin; TAA, triamcinolone acetonide; TAD, triamcinolone diacetate. (B) BME activates phd3:eGFP in an RU-486-dependent manner; representative images show the activation specific to the liver in BMEtreated embryos and reduced GFP expression following BME+RU-486 cotreatment. (Magnification: 16×.) (C) Quantitation of phd3:eGFP response. DMSO was added to 1% vol/vol in all experiments except Control (C), DMOG to 60 μM, and RU-486 to 5 μM as indicated (n ≥ 9). (D) BME induction of hypoxia-regulated genes and GC target genes, where values above bars indicate average fold change (FC) and triplicate samples of 20 embryos were used. For the hypoxia-induced genes, FC induction in vhl mutants vs. wild type is given as a comparison, where FC is calculated using ΔΔCT ± SEM. (E) HIF1β-MO abrogates BME activation of phd3:eGFP. Maximum pixel intensity in embryos as grouped by injection showing mean ± SEM (n = 14). Significance was calculated using Kruskal-Wallis one-way ANOVA followed by Dunn's multiple comparison test for treatments against DMSO (*P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). Values represent the mean ± SEM (***P < 0.001; **P < 0.01; *P < 0.05). A.U., arbitrary units.
underlying GC/HIF cross-talk, we assessed whether DEX-induced effects on HIF-reporter activity were dependent on GR and its DNA binding activity. Single-cell stage Tg(4xhre-tata:eGFP) ia21 embryos were microinjected with a splice-blocking MO against full-length GR (gr-MO) (21) . Real-time PCR analysis of fkbp5 showed significantly reduced expression to confirm gr-MO activity (Fig. S3C ). Morphants and control Tg(4xhre-tata:eGFP) ia21 embryos (48 hpf) were incubated with or without DEX (10 μM) for 24 h, and reporter activity was measured. DEX increased 4xhre-tata activity in controls but had minimal effect on the gr morphants ( Fig. 3 B and C) . Moreover, HIF activation was independently confirmed by measuring endogenous phd3 mRNA expression in 72-hpf gr morphants and control embryos (Fig. 3D) . Finally, GR dependency of HIF transcriptional activation was observed in a CRISPR-induced null mutant of the GR gene (Fig. S3D) .
We also studied the zebrafish gr s357 mutant (22) that lacks DNAbinding function and abrogates GR transcriptional activity (Fig. 4A) . Interestingly, DEX activated the Tg(4xhre-tata:eGFP) ia21 reporter in a gr s357 mutant background (Fig. 4B ), suggesting that a nontranscriptional mechanism underlies GC activation of HIF signaling. To independently assess the role of the GR DNA-binding domain in GC/HIF cross-talk, offspring from two gr s357 homozygous carriers (72 hpf) were incubated with DEX or BME, and phd3 mRNA levels were analyzed by WISH (Fig. 4 C-E) . DEX and BME activated phd3 transcription in both wild-type and gr s357 mutant embryos, confirming that HIF transcriptional activity was preserved.
GCs Activate HIF Signaling in Human Hepatocytes. To verify whether the GC/HIF cross-talk observed in zebrafish is relevant to humans, we focused our efforts on human liver-derived cells. Culturing hepatocyte-derived Huh-7 cells under low oxygen stabilized HIF-1α at comparable levels to prednisolone treatment ( Fig. 5 A and  B) . To assess transcriptional responses, Huh-7 cells were transfected with a hre-luciferase (hre-luc) reporter and treated with prednisolone and dexamethasone that activated the reporter (Fig.  5C ). Furthermore, prednisolone induced mRNA levels of three endogenous HIF target genes (VEGF, PDK, and GLUT1) to a similar degree as low-oxygen treatment, thus paralleling the in vivo results observed in zebrafish embryos (Fig. 5D) . Furthermore, GC activation of HRE activity was sensitive to the GR antagonist RU-486 (Fig. 5D) 
target genes were induced by prednisolone, whereas only 3 of 38 were induced by cortisone (Dataset S2).
To confirm that the response is not simply a result of using immortalized Huh-7 cells, we showed that prednisolone activated the HRE reporter in primary human hepatocytes (Fig. 5E ). To ascertain whether GCs increase HIF expression and associated transcriptional activity in an authentic liver microenvironment, we treated human liver slices with prednisolone or culture under low oxygen (3%) for 16 h and imaged nuclear HIF-1α (Fig. 6A) and quantified HIF target gene mRNA levels (Fig. 6 B and C) . Both prednisolone and low-oxygen treatments stabilized HIF-1α (Fig.  6A ) and increased HIF target gene expression (Fig. 6 B and C) .
Together, these data demonstrate that, as in the zebrafish, GCs can activate HIF signaling in the human liver.
To determine how GCs activate HIF signaling, we investigated the effect of GCs on pVHL expression, a crucial negative regulator of HIFα protein. We showed that GCs reduce pVHL expression in Huh-7 cells (Fig. 6D) . This is unlikely to be mediated by a transcriptional mechanism since VHL mRNA levels were not affected (Fig. S4A) . pVHL is degraded by the proteasome (Fig. 6D) following posttranslational modification by kinases such as c-src and CKII (24) . Indeed, we found that inhibiting c-src activity with PP2 (25) rescued the inhibitory effects of GC on VHL expression (Fig.  6E) , blocked HIF-1α induction (Fig. 6F) , and normalized HIF (24 h) compared with nontreated/noninjected controls (set at 1). Target gene mRNA levels were normalized to β-actin. *P < 0.05; ***P < 0.001. target gene expression (Fig. S4B) , suggesting a mechanism for GCs to stabilize HIFs via degrading VHL.
Discussion
The Spectrum Collection (Microsource Discovery Systems) includes compounds that modulate a wide variety of pathways; however, only GCs showed a consistent and robust HIF activation. It is surprising that GCs were not previously identified as HIF modifiers in cell-based chemical screens. We can only speculate what the apparent liver specificity of the GC effect may have contributed. Thus, in vivo chemical screens, providing a variety of cell types in a physiological context, are a useful expansion compared with more classical screening approaches, even with "well-trodden" pathways like HIF.
We confirmed that GCs promote HRE-dependent HIF transcriptional activity in fish and human liver cells. Surprisingly, fish expressing a GR mutant lacking a functional DNA-binding domain (DBD) still activated the phd3 promoter and 4xhre reporter models after treatment with DEX. However, complete knockdown of GR and a newly generated truncated GR mutant abrogated the ability of DEX to stabilize HIF. The GR is essential for survival as demonstrated by the report that 90% of GR KO mice die soon after birth (26) and only 10% of GR KO zebrafish survive, with a reduced fitness. Of note, both mouse and zebrafish homozygous mutants of the GR-DBD survive with minor defects (22, 27) , suggesting essential roles for GRE-independent GR activities, as exemplified by our study.
Since GCs are reported to activate c-src kinase (28, 29) , which is known to phosphorylate and target pVHL for proteosomal degradation (24), we hypothesized a role for GCs in stabilizing HIF via c-src degradation of VHL. Consistent with our results, RU-486 inhibited such nongenomic effects of GR (30) . Our in vitro studies confirm that GCs destabilize VHL protein expression, and this was rescued by cotreating cells with the c-src inhibitor PP2 (Fig. 6E) . As VHL is a negative regulator of HIF, this results in HIF expression under normoxic conditions.
Although we see activation of phd3 and 4xhre promoters and other hypoxia response genes by GCs, GCs do not fully replicate a hypoxic response. We find increased expression of many HIF target genes (Dataset S2), but some exceptions were noted such as Enolase1 and Carbonic anhydrase 9, which were downregulated by prednisolone. A direct interaction between ligandactivated GR and HIF proteins cannot be excluded, as Kodama et al. (5) have suggested that GR binds the HIF dimer. However, a simpler explanation is that, in addition to stabilizing HIF protein, GR binds a subset of promoters to regulate transcription. A complex interplay is suggested by other reports: for example, while HIF up-regulates VEGF expression and promotes angiogenesis, GCs are generally angiostatic (31) and negatively regulate VEGF expression (32) (33) (34) . Similarly, during high altitude sickness, GC and HIF may have apparently opposing effects (35, 36) . Therefore, we propose that the interplay that we have identified is likely to be tissue-and possibly context-specific.
We found that GC agonists increased mRNA levels of the classical HIF target erythropoietin both in cell culture (Dataset S2) and in zebrafish embryos and adult zebrafish livers (Fig. S5) . Our data are consistent with reports showing a synergistic effect of GCs and HIFs in hematopoiesis (37, 38) , and it will be interesting to investigate whether this cooperativity is GR-DBD-dependent. GCs received their name because they promote blood glucose levels as well as gluconeogenesis and glycogen storage in the liver and provide an acute response to stress (39) . HIF signaling has a profound impact on cellular metabolism and induces gluconeogenesis and glycogen storage (40, 41) . We suggest that GCs modulation of VHL and HIF may contribute to their ability to modulate blood glucose and glycogen storage. In addition, HIF has been shown to impact lipid metabolism in the liver, where its (in)appropriate activation reduces beta oxidation and increases lipid storage capacity leading to steatosis (42, 43) . It is worth noting that long-term treatment with GCs was reported to increase steatosis (44) . Activation of the HIF pathway via cross-talk with the GR may explain how GC excess regulates hepatic fat metabolism and the steatotic phenotype. Our experiments show that GCs predominantly stabilize HIF in the liver and may activate only a subset of HIF targets, which could be addressed by studying tissuespecific knockout models. Based on the elegant experiments of Rankin et al. (43), we would predict that liver-specific deletion of HIF-2a should protect mice from GC-induced steatosis and may reduce the effect of GCs on blood glucose levels.
It is becoming clear that HIF signaling is regulated not only by low oxygen, but also by several other inflammatory mediators (45) (46) (47) . Our data support GC as a further key modulator of HIF signaling to add to this growing list. It is interesting to note that many common GC and HIF gene targets are implicated in regulating hepatic metabolism. This is potentially important, as GCs are secreted in a rhythmic circadian fashion, where circulating GC levels reach a maximum to coincide with the onset of the active phase-morning in humans, evening in mice. Since metabolic processes in the liver are coupled to the circadian clock, our data provide an additional level of control, where GC activation of the HIF pathway helps to ensure that the changing metabolic demands throughout the day are met. Our data suggest a role for GC-driven circadian components in other aspects of HIF signaling.
Material and Methods
Zebrafish Strains. vhl mutant and Tg(phd3:eGFP) i144/i144 (13) fish were maintained in a mixed Tupfel long fin/London wild-type (TL/LWT) background. The Tg (9xGCRE-HSV.Ul23:eGFP) ia20 line is a GC pathway reporter (23) . The zebrafish GR mutant line gr s357 was incrossed to create homozygotes (22) . mutants were used as positive controls. Biological replicates of 48-hpf Tg(4xhre-tata:eGFP) ia21 embryos were incubated with or without 10 μM DEX and/or 3.8 μM 17-AAG (Sigma) for 24 h. RNA was isolated using TRIzol and quantified using the Nanodrop ND-1000 spectrophotometer. cDNA was reverse-transcribed from 0.5 μg RNA using the SuperScript III First-Strand Synthesis System (Invitrogen). For the temporal phd3 expression profile, qPCR was performed with optimized primers, using the iCycler iQ system (Bio-Rad). Cycling conditions were the following: 95°C − Cycle threshold (Ct) values were calculated automatically using the software, with ROX reference dye as the passive reference. Fold change was calculated using the ΔΔCT method.
MO and mRNA Injections. The translation-blocking MO HIFβ-MO (GGATTAG-CTGATGTCATGTCCGACA) was used as reported (18) while a splice-site targeting MO (gr-MO) was used to silence GR (21) . A standard control MO (CTRL-MO; Genetools) was used as a negative control. The MO stock solution (8 mg/mL) was diluted in Danieau's solution, and ∼2 nL was injected per embryo as previously described (48) . Dominant-active hif-1αa and hif-1αb (kindly provided by P. Elks, University of Sheffield, Sheffield, UK) were synthesized (mMessageMachine; Ambion, Invitrogen) and injected as described in ref. 49 .
Image Analysis in Tg(4xhre-tata:eGFP) ia21 Embryos. For analysis of Tg(4xhre-tata: eGFP) ia21 embryos, fluorescence was collected using a Leica M165FC dissecting microscope and a Nikon C2 H600L confocal microscope. N-phenylthioureatreated larvae were anesthetized with tricaine and embedded in 1% lowmelting agarose on a glass slide. Images were analyzed with Nikon software. For fluorescence quantification of transgenic embryos, a Leica M165FC microscope and DC500 digital camera were used. All images were acquired using identical parameters, and fluorescence-integrated density was calculated using ImageJ.
Cell Culture, Antibodies, and Treatments. Huh-7 and HEK293 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% FBS, 1% L-glutamine, and 50 units/mL penicillin/streptomycin (Life Technologies). Primary human hepatocytes were isolated as described (50) (51) . Briefly, the core was placed into the slicer assembly under aseptic conditions, and 240-μm sections were collected and immediately transferred into Williams E media/1% L-glutamine/0.5 μM insulin. An albumin ELISA (Bethyl Laboratories) was used to monitor the viability of the slices. Samples from five donors were serum-starved followed by incubation under hypoxia (3% O 2 ) or normoxia (20% O 2 ) for 24 h. Liver slices were treated with prednisolone (100 nM) for 24 h before fixing for detection of HIF-1α by confocal microscopy.
Confocal Microscopy on Cells. Cells were grown on 13-mm borosilicate glass coverslips at a density of 4 × 10 4 /well for 24 h and serum-starved for 5 h before treating with prednisolone (100 nM). Cells or liver slices were fixed in 3% paraformaldehyde for 25 min at room temperature (RT) and permeabilized with 0.01% TX-100/PBS for 10 min. Cells were incubated with anti-HIF-1α for 1 h at RT, unbound antibody was removed by washing, and bound antibody was detected with Alexa-488 secondary antibody. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole, dihydrochlorine (DAPI; Life Technologies). Cells were imaged using a Zeiss Meta Head confocal microscope with a 63× water immersion objective.
HRE Reporter Assay. Cells were transfected with the HRE reporter (a plasmid containing four tandem HRE copies kindly provided by M. Ashcroft, Cambridge University, Cambridge, UK) using Fugene 6 transfection reagent (Promega) per the manufacturer's guidelines. After 24 h, cells were serum-starved for 5 h before treating with GC or RU-486, (100 nM) for a further 24 h. Cells were lysed, and reporter activity was quantified using a firefly luciferase assay system (Promega) in a luminometer (Berthold Lumat LB 9507).
Western Blotting. Cells were harvested in lysis buffer (PBS/1% Triton-X100/ 0.1% Na deoxycholate/0.1% SDS) containing protease and phosphatase inhibitors (Roche). Lysates were clarified by centrifugation, and protein concentration was determined using a Bradford Protein Assay Reagent (Pierce). Protein lysates (20 μg) were added to sample running buffer (30% glycerol/ 6% SDS/0.02% bromophenol blue/10% 2-β-mercaptoethanol/0.2 M Tris·HCl; pH 6.8) and separated by SDS/PAGE. Separated proteins were transferred to PVDF membranes and incubated with primary antibodies before detection with HRP-conjugated secondary antibody and enhanced chemiluminescence (Geneflow) using a PXi imaging system (Syngene).
